Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with Dementia

failing memory1 - senile atrophy and aphasia1 - app3 - cognitive function9 - high oestrogen levels1 - sign of alzheimer's1 - atorvastatin1 - mentally weak1 - neuropsychological tests1 - alzheimer's imaging agents1 - alzheimer’s disease8 - cognitive problems2 - type of dementia4 - cyclophilin a1 - haldol1 - alcohol consumption1 - ftld4 - olive oil1 - traumatic forms of dementia1 - abeta1 - thomas willis1 - brain disorder1 - razadyne1 - psychomotor retardation1 - neurofilaments1 - brain tissue1 - low-density lipoprotein receptor-related protein 61 - brain damage2 - dementia of the alzheimer type1 - dementia sufferers1 -